Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Pozniak

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Initiation of antiretroviral therapyAnton Pozniak
Journal of HIV Therapy|April 17, 2002
Mycobacterial diseases and HIVAnton Pozniak
Drugs of Today (Barcelona, Spain : 1998)|August 31, 2007
The first once-daily single-tablet regimen for the treatment of HIV-infected patientsBen Killingley, Anton Pozniak
Clinics in Dermatology|February 22, 2024
The global burden of HIVSashini Payagala, Anton Pozniak
The Journal of Antimicrobial Chemotherapy|August 21, 2008
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugsMarta Sousa, Anton Pozniak, Marta Boffito
Journal of Clinical Pharmacology|January 25, 2006
Practical perspectives on the use of tipranavir in combination with other medications: lessons learned from pharmacokinetic studiesMarta Boffito, Desmond Maitland, Anton Pozniak
Journal of Virus Eradication|February 26, 2019
Are new antiretroviral treatments increasing the risks of clinical obesity?Andrew Hill, Laura Waters, Anton Pozniak
Journal of the International AIDS Society|November 14, 2014
Large disparities in HIV treatment cascades between eight European and high-income countries - analysis of break pointsAlice Raymond, Andrew Hill, Anton Pozniak
BMJ Case Reports|August 24, 2021
A case of pulmonary nodules in a patient living with HIV diagnosed with secondary syphilisNatasha Bell, Margherita Bracchi, Anton Pozniak
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2016
Critical Review: What Dose of Rifabutin Is Recommended With Antiretroviral Therapy?H Manisha Yapa, Marta Boffito, Anton Pozniak
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Current Opinion in HIV and AIDS|April 18, 2009
Initiation of antiretroviral therapyAnton Pozniak
Journal of HIV Therapy|April 17, 2002
Mycobacterial diseases and HIVAnton Pozniak
Drugs of Today (Barcelona, Spain : 1998)|August 31, 2007
The first once-daily single-tablet regimen for the treatment of HIV-infected patientsBen Killingley, Anton Pozniak
Clinics in Dermatology|February 22, 2024
The global burden of HIVSashini Payagala, Anton Pozniak
The Journal of Antimicrobial Chemotherapy|August 21, 2008
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugsMarta Sousa, Anton Pozniak, Marta Boffito
Journal of Clinical Pharmacology|January 25, 2006
Practical perspectives on the use of tipranavir in combination with other medications: lessons learned from pharmacokinetic studiesMarta Boffito, Desmond Maitland, Anton Pozniak
Journal of Virus Eradication|February 26, 2019
Are new antiretroviral treatments increasing the risks of clinical obesity?Andrew Hill, Laura Waters, Anton Pozniak
Journal of the International AIDS Society|November 14, 2014
Large disparities in HIV treatment cascades between eight European and high-income countries - analysis of break pointsAlice Raymond, Andrew Hill, Anton Pozniak
BMJ Case Reports|August 24, 2021
A case of pulmonary nodules in a patient living with HIV diagnosed with secondary syphilisNatasha Bell, Margherita Bracchi, Anton Pozniak
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2016
Critical Review: What Dose of Rifabutin Is Recommended With Antiretroviral Therapy?H Manisha Yapa, Marta Boffito, Anton Pozniak
Pageof 17